APA (7th ed.) Citation

Jawhar, M., Schwaab, J., Metzgeroth, G., Kluger, S., Naumann, N., Hofmann, W., . . . Reiter, A. (2016). Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+ advanced systemic mastocytosis. Leukemia, 30(1), . https://doi.org/10.1038/leu.2015.284

Chicago Style (17th ed.) Citation

Jawhar, Mohamad, Juliana Schwaab, Georgia Metzgeroth, Sebastian Kluger, Nicole Naumann, Wolf-Karsten Hofmann, Alice Fabarius, and Andreas Reiter. "Additional Mutations in SRSF2, ASXL1 And/or RUNX1 Identify a High-risk Group of Patients with KIT D816V+ Advanced Systemic Mastocytosis." Leukemia 30, no. 1 (2016). https://doi.org/10.1038/leu.2015.284.

MLA (9th ed.) Citation

Jawhar, Mohamad, et al. "Additional Mutations in SRSF2, ASXL1 And/or RUNX1 Identify a High-risk Group of Patients with KIT D816V+ Advanced Systemic Mastocytosis." Leukemia, vol. 30, no. 1, 2016, https://doi.org/10.1038/leu.2015.284.